Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Importance of lymph node immune responses in MSI-H/dMMR colorectal cancer
Koji Inamori, … , Masaaki Ito, Hiroyoshi Nishikawa
Koji Inamori, … , Masaaki Ito, Hiroyoshi Nishikawa
Published March 23, 2021
Citation Information: JCI Insight. 2021;6(9):e137365. https://doi.org/10.1172/jci.insight.137365.
View: Text | PDF
Research Article Oncology

Importance of lymph node immune responses in MSI-H/dMMR colorectal cancer

  • Text
  • PDF
Abstract

Patients with colorectal cancers (CRCs) generally exhibit improved survival through intensive lymph node (LN) dissection. However, recent progress in cancer immunotherapy revisits the potential importance of regional LNs, where T cells are primed to attack tumor cells. To elucidate the role of regional LN, we investigated the immunological status of nonmetastatic regional LN lymphocytes (LNLs) in comparison with those of the tumor microenvironment (tumor-infiltrating lymphocytes; TILs) using flow cytometry and next-generation sequencing. LNLs comprised an intermediate level of the effector T cell population between peripheral blood lymphocytes (PBLs) and TILs. Significant overlap of the T cell receptor (TCR) repertoire was observed in microsatellite instability–high/mismatch repair–deficient (MSI-H/dMMR) CRCs with high tumor mutation burden (TMB), although limited TCRs were shared between nonmetastatic LNs and primary tumors in microsatellite stable/MMR proficient (MSS/pMMR) CRC patients with low TMB. In line with the overlap of the TCR repertoire, an excessive LN dissection did not provide a positive impact on long-term prognosis in our MSI-H/dMMR CRC cohort (n = 130). We propose that regional LNs play an important role in antitumor immunity, particularly in MSI-H/dMMR CRCs with high TMB, requiring care to be taken regarding excessive nonmetastatic LN dissection in MSI-H/dMMR CRC patients.

Authors

Koji Inamori, Yosuke Togashi, Shota Fukuoka, Kiwamu Akagi, Kouetsu Ogasawara, Takuma Irie, Daisuke Motooka, Yoichi Kobayashi, Daisuke Sugiyama, Motohiro Kojima, Norihiko Shiiya, Shota Nakamura, Shoichi Maruyama, Yutaka Suzuki, Masaaki Ito, Hiroyoshi Nishikawa

×

Figure 3

PD-1 expression by T cells in PBLs, LNLs, and TILs.

Options: View larger image (or click on image) Download as PowerPoint
PD-1 expression by T cells in PBLs, LNLs, and TILs.
PBLs, LNLs, and TILs...
PBLs, LNLs, and TILs from 21 CRC patients who received surgical resection were examined with flow cytometry as in Figure 1. (A) Representative flow cytometry staining (left) and summaries (right) for the frequency of PD-1–expressing cells in CD4+ and CD8+ T cells in PBLs, LNLs, and TILs. (B) Summaries for the frequency of PD-1–expressing cells in total CD4+ T cells, CCR7+CD45RA+CD4+ T cells (naive), CCR7+CD45RA–CD4+ T cells (central memory), CCR7–CD45RA–CD4+ T cells (effector memory), and CCR7–CD45RA+CD4+ T cells (terminally differentiated effector memory) in PBLs, LNLs, and TILs. (C) Summaries for the frequency of PD-1–expressing cells in total CD8+ T cells, CCR7+CD45RA+CD8+ T cells (naive), CCR7+CD45RA–CD8+ T cells (central memory), CCR7–CD45RA–CD8+ T cells (effector memory), and CCR7–CD45RA+CD8+ T cells (terminally differentiated effector memory) in PBLs, LNLs, and TILs. Means ± SDs are shown, and statistical analyses were performed using 1-way ANOVA with Bonferroni corrections. CM, central memory; EM, effector memory; TEMRA, terminally differentiated effector memory; PB, peripheral blood; dLN, distal LN; pLN, proximal LN.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts